CompaniesCeltic Biotech

Celtic Biotech

active

Dublin, Ireland

Founded 2003

About

Snake-venom derived cancer therapies

Areas of Focus

Categories

Small Molecule Pharmaceutical

Team (9)

David Prestwich, CTA

Chief Finance Officer

Dr Dorothy Bray, PhD

Director of Clinical Affairs

Dr. François-Michel Delgado MD

Dr. Margit Jeschke

Product IP and Strategy

Dr. Maria Angeles Gil-Delgado MD

Consultant Medical Oncologist, Pitié-Salpetriere Hospital, Paris

Dr. Paul Reid, PhD

CEO, Director and co-founder of Celtic Biotech

executivefounder

View all 9 team members →

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

24

By Phase

PHASE1: 1

By Status

NOT_YET_RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT01481532Lead Sponsor

Open Label Clinical Trial of Intravenous Crotoxin Part 3

PHASE1Not yet recruiting

24 participants

Started: Aug 31, 2024 · Completed: Dec 31, 2025

Locations (1)

Headquarters

Dublin, Ireland

Map

Loading map...